Professional and Patient Expert recruitment:

Deadline for responses: midnight on Tuesday 27 January 2026

Status:
In progress
Technology type:
Device
Decision:
Selected
Reason for decision:
Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
ID number:
10084
Description:
A lung transplant may be an option for people with end-stage respiratory failure. This can be caused by life-limiting conditions such as idiopathic pulmonary fibrosis, cystic fibrosis, chronic obstructive pulmonary disease and pulmonary hypertension. The NHS faces a critical shortage of donor organs. In September 2025, there were 176 people on the lung transplant waiting list and 12 people on the heart and lung transplant waiting list. Only a small proportion of lungs from deceased donors meet transplant standards, often because of the donor’s cause of death or trauma. In some cases, donor lungs that do not meet the standard criteria for transplantation (marginal lungs) can still be used under certain conditions. Other reasons for shortages include logistical issues and mismatches between donors and recipients. Standard lung transplant protocol involves cold preservation to maintain the donor lungs. Ex-situ machine perfusion devices deliver an oxygenated solution to the donor lung and keeps it at normal body temperature. The aim is to reverse damage to the lung, increase the time the lung can be stored, and allow assessment of how well the lung works before it is transplanted. This technology may allow more donor lungs to be used for transplant.

Provisional Schedule

Scope published:
10 March 2026

Project Team

Project lead
Deonee Stanislaus

Email enquiries

If you have any queries please email HealthTech1@nice.org.uk

Timeline

Key events during the development of the guidance:

Date Update
16 December 2025 In progress. Scoping starts
15 September 2025 Awaiting development. Status change linked to Topic Selection Decision being set to Selected

For further information on our processes and methods, please see our HealthTech programme manual.